Genetic manipulation is hard to control and contain/direct. Multi-generational monitoring is vital to reducing the risk of catastrophic changes to the human genome. We need new regulatory legislation to reduce the costs of research and the profit-pressures of pushing a treatment through faster. That must go hand-in-hand with patent rights, especially as Congress eyes new 101 fixes!

View the article.